Adverse Event

Adverse Event

An adverse event (AE) is any unwanted medical event in a trial participant or patient given a drug, whether or not the drug caused it. Adverse events range from mild and short-lived (such as nausea or headache) to serious and life-threatening (such as pancreatitis or anaphylaxis). Collecting, classifying and reporting them carefully is central to judging a drug’s safety in clinical trials.

Adverse events are graded by severity (mild, moderate, severe), by seriousness (serious adverse events, or SAEs, are those that cause death, hospitalization or disability, or are life-threatening) and by whether investigators think the study drug caused them. In retatrutide trials, the most common adverse events have been gastrointestinal, including nausea, diarrhea, vomiting and constipation, as expected from GLP-1 receptor activity. Most were mild to moderate and tended to happen while the dose was being increased.

An adverse event is not the same as a side effect. “Side effect” implies the drug caused the problem. “Adverse event” is broader and covers everything unfavorable that happens during treatment, including events that may be coincidental. Regulators such as the FDA require full adverse event reporting so they can weigh a drug’s benefits against its risks.